A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs.

NPJ Precis Oncol · 2023 · PMC10713594 · PMID 38081998

Europe PMC DOI

hedged sentence

0.3340

closest p · 6.7× alpha

0.3340

boldest claim

The sentences

did not reach statistical significanceP = 0.334not close (p > 0.1)

4a and Supplementary Table 1 , while the AUC differences between the clinical score (CAPRA) and NAFNet-classifier did not reach statistical significance ( P = 0.334), DL-nomogram had a significantly higher AUC value than the clinical score (CAPRA) ( P < 0.001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.